Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population

Multi-Ethnic Analysis of Cardiac Pharmacogenetic Markers of Cytochrome P450 and Membrane Transporters Genes in the Russian Population

Aim. To summarize Russian studies using pharmacogenetic testing as applied to cardiology.Material and methods. The authors conducted an online search for articles in December 2018 using the following databases: PubMed, Google Scholar, eLIBRARY. The search was carried out by keywords: "Russia&qu...

Full description

Bibliographic Details
Main Authors:	K. B. Mirzaev, D. S. Fedorinov, D. V. Ivashchenko, D. A. Sychev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2019-07-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	pharmacogenetics pharmacogenomics cytochrome p450 cardiology coronary heart disease arterial hypertension
Online Access:	https://www.rpcardio.online/jour/article/view/1963

Similar Items

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children
by: Ida Aka, et al.
Published: (2017-11-01)

Pharmacogenetics of schizophrenia in real clinical practice: a clinical case
by: R. F. Nasyrova, et al.
Published: (2018-12-01)

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment
by: Grace Zdesenko, et al.
Published: (2022-06-01)

Pharmacogenomics of cytochrome P450 3A4 (CYP3A4): recent progress towards the missing heritability problem
by: Kathrin eKlein, et al.
Published: (2013-02-01)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
by: Bradley Roberts, et al.
Published: (2023-09-01)

Assessment of Substrate Status of Drugs Metabolized by Polymorphic Cytochrome P450 (CYP) 2 Enzymes: An Analysis of a Large-Scale Dataset
by: Jakob Sommer, et al.
Published: (2024-01-01)

Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome
by: Janice Forster, et al.
Published: (2021-01-01)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020-08-01)

Impact of sex on antidepressant discontinuation in groups of similar cytochrome P450 phenotypes
by: Dylan L. Kosaski, PharmD, et al.
Published: (2023-12-01)

Distinct Effects of Inflammation on Cytochrome P450 Regulation and Drug Metabolism: Lessons from Experimental Models and a Potential Role for Pharmacogenetics
by: Laura M. de Jong, et al.
Published: (2020-12-01)

Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: The first meta-analysis of Russian prospective studies
by: D A Sychev, et al.
Published: (2014-04-01)

ADME Gene-Related Pharmacogenomic Labeling of FDA-Approved Drugs: Comparison with Clinical Pharmacogenetics Implementation Consortium (CPIC) Evidence Levels
by: Subrata Deb, et al.
Published: (2024-02-01)

Establishment of a Pharmacogenetics Service Focused on Optimizing Existing Pharmacogenetic Testing at a Large Academic Health Center
by: Amy L. Pasternak, et al.
Published: (2020-10-01)

Pharmacogenetics of the safety of phenazepam in alcohol withdrawal syndrome: haplotype and combinatorial analyses of polymorphic variants in the pharmacokinetic factor genes
by: D. V. Ivashchenko, et al.
Published: (2020-04-01)

Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners
by: Denise van der Drift, et al.
Published: (2023-09-01)

Engineering cytochrome P450s for bioremediation /
by: 242771 Kellner, David G., et al.

The concept of gene is in crisis. Does it affect pharmacogenetics and pharmacogenomics?
by: Miriam Falkenberg, et al.
Published: (2006-09-01)

Association of polymorphism of CYP2D6 and CYP2C9 genes encoding P-450 proteins of cytochrome with arterial hypertension
by: Saratsev A.V., et al.
Published: (2012-12-01)

Pathway-targeted pharmacogenomics of CYP1A2 in human liver
by: Kathrin eKlein, et al.
Published: (2010-11-01)

Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review
by: Sylvia D. Klomp, et al.
Published: (2020-09-01)

The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
by: Freeborn Rwere, et al.
Published: (2021-09-01)

The use of active site mutants of cytochrome P450(cam) in chemical synthesis
by: Bell, S, et al.
Published: (1999)

Characteristics and roles of cytochrome b5 in cytochrome P450-mediated oxidative reactions in Locusta migratoria
by: Jiao LIU, et al.
Published: (2020-06-01)

P450 Pharmacogenetics in Indigenous North American Populations
by: Lindsay M. Henderson, et al.
Published: (2018-02-01)

The Effects of Personal Pharmacogenetic Testing on the Effects of Pharmacy Student Perceptions of Knowledge and Attitudes Towards Precision Medicine
by: Dalga D Surofchy, PharmD (c), et al.
Published: (2017-01-01)

Pharmacogenomics to Predict Tumor Therapy Response: A Focus on ATP-Binding Cassette Transporters and Cytochromes P450
by: Viktor Hlaváč, et al.
Published: (2020-08-01)

Pharmacogenetics of alcohol addiction: current perspectives
by: Zastrozhin MS, et al.
Published: (2019-07-01)

Analysis of the complications of endocrine therapy with tamoxifen in breast cancer: clinical and pharmacogenetic aspects. Prospective pharmacogenetic cohort study
by: Marina I. Savelyeva, et al.
Published: (2022-11-01)

Clinical and statistical consideration in personalized medicine /
by: Carini, Claudio, et al.
Published: (2014)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023-03-01)

Star allele search: a pharmacogenetic annotation database and user-friendly search tool of publicly available 1000 Genomes Project biospecimens
by: N. Gharani, et al.
Published: (2024-01-01)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC®) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
by: Christopher Blazy, et al.
Published: (2022-06-01)

Gut transcriptome analysis of P450 genes and cytochrome P450 reductase in three moth species feeding on gymnosperms or angiosperms
by: Xiaoman Zhang, et al.
Published: (2022-11-01)

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients
by: Sepideh Zununi Vahed, et al.
Published: (2015-02-01)

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications
by: Marin Veldic, et al.
Published: (2019-02-01)

Interaction of rocuronium with human liver cytochromes P450
by: Eva Anzenbacherova, et al.
Published: (2015-02-01)

Pharmacogenetics of antiepileptic drugs (literature review)
by: E. . Bochanova
Published: (2018-05-01)

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode
by: Milica Pjevac, et al.
Published: (2023-08-01)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
by: Irina Piatkov, et al.
Published: (2012-10-01)

Cytochrome p450 and innovative nutraceutical products
by: Francesco Frati, et al.
Published: (2024-03-01)